Study at a glance
Did vitamin D3 change the response to chemotherapy before breast-cancer surgery?
Researchers tested vitamin D3 during chemotherapy given before breast-cancer surgery. Eighty women aged 45 or older were assigned by chance to vitamin D3 or an inactive treatment called a placebo. The vitamin D3 dose was 2,000 international units (IU) each day for six months.
What did the breast tissue results show after treatment?
Seventy-five women completed chemotherapy and had surgery. In 43% of women given vitamin D3 and 24% given placebo, no remaining invasive cancer was found in the tissue examined. This is called a pathological complete response. Blood levels of the measured form of vitamin D, called 25-hydroxyvitamin D, also rose with vitamin D3.
Does this prove that vitamin D treats breast cancer or improves survival?
The finding concerns response to chemotherapy in this trial. It does not establish that vitamin D alone treats breast cancer. The reported outcome is not the same as proving a longer-term survival benefit.
Read the full article below ↓Study overview
Omodei M S et al. (2025) tested whether vitamin D3 supplementation could improve pathological complete response rates in women receiving neoadjuvant chemotherapy for breast cancer. This randomized clinical trial was published in Nutrition and Cancer.
What this study shows
In women with breast cancer undergoing neoadjuvant chemotherapy, daily vitamin D3 (2,000 IU) for 6 months increased serum 25(OH)D levels and was associated with a higher pathological complete response rate than placebo (43% vs 24%). In adjusted analysis reported by the authors, achieving 25(OH)D levels at or above 20 ng/mL was associated with higher odds of pathological complete response.
Key details
- Design: randomized clinical trial
- Participants: 80 women aged 45+ eligible for neoadjuvant chemotherapy; 75 completed treatment and underwent surgery
- Intervention: vitamin D3 (cholecalciferol) 2,000 IU/day for 6 months vs placebo
- Outcomes measured: pathological complete response (primary), serum 25(OH)D
- Main finding direction: higher pCR rate with vitamin D supplementation
Primary source
Vitamin D Supplementation Improves Pathological Complete Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Randomized Clinical Trial (PubMed)
Related reading
A 3′‐pre‐tRNA‐derived small RNA tRF‐1‐Ser regulated by 25(OH)D promotes proliferation and stemness by inhibiting the function of MBNL1 in breast cancer
We explored the potential novel anticancer mechanisms of 25‐hydroxyvitamin D (25(OH)D), a vitamin D metabolite with antitumour effects in breast cancer.
Original paper ↗Read more →A Retrospective Interventional Study Examining Whether Successful Replacement Therapy After a Confirmed Vitamin D Deficiency Correlates with Improved Disease-Free Survival in the Curative Intent Treatment of HER2+ Breast Cancer
Leveraging this unique clinical practice, we examined whether successful correction of vitamin D deficiency was associated with improved disease-free survival among patients with HER2-positive breast cancer.
Original paper ↗Read more →Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial
Differences in mean changes for outcomes were evaluated using mixed-model repeated measure analysis.
Original paper ↗Read more →Calcitriol promotes M2 polarization of tumor-associated macrophages in 4T1 mouse mammary gland cancer via the induction of proinflammatory cytokines
Our research found that vitamin D3 (VD3) treatment increased lung metastasis in mice with 4T1 murine breast cancer (BC).
Original paper ↗Read more →Course of Vitamin D Levels in Newly Diagnosed Non-Metastatic Breast Cancer Patients over One Year with Quarterly Controls and Substitution
(1) Background: Vitamin D levels in patients remain inadequately understood, with research yielding inconsistent findings.
Original paper ↗Read more →Cytoprotective Effect of Vitamin D on Doxorubicin-Induced Cardiac Toxicity in Triple Negative Breast Cancer
We evaluated whether vitamin D may prevent Dox-induced cardiotoxicity in a mouse TNBC model.
Original paper ↗Read more →Determinants of Plasma 25-Hydroxyvitamin D Concentrations among Breast Cancer Survivors in Korea
We identified demographic, lifestyle, and clinical factors associated with vitamin D status among breast cancer survivors.
Original paper ↗Read more →Dietary supplement intake in women with breast cancer before and after diagnosis: results from the SUCCESS C trial
The aim of the present analysis was to assess the prevalence of dietary supplement (DS) intake among women before and after a breast cancer diagnosis.
Original paper ↗Read more →Factors Associated with Long-Term Dietary Supplement Use among Korean Breast Cancer Survivors: A Cross-Sectional Study
Purpose: The factors associated with the dietary supplement (DS) use of Asian breast cancer survivors in consideration of the duration of use and types of DS have not been well established.
Original paper ↗Read more →Factors associated with mammographic breast density among women in Karachi Pakistan
Participants included 477 women, who had received either diagnostic or screening mammography at two hospitals in Karachi Pakistan.
Original paper ↗Read more →Food groups and micronutrients associated with chemotherapy-induced peripheral neuropathy in survivors of cancer post-neurotoxic treatment
In this cross-sectional study, participants completed the PRO-CTACE™ numbness and tingling severity item and VioScreen™ Research Food Frequency Questionnaire to determine CIPN status and dietary intake, respectively.
Original paper ↗Read more →Investigating the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors
This study aimed to investigate the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors.
Original paper ↗Read more →Negative Impact of 25-hydroxyvitamin D Deficiency on Breast Cancer Survival
Low 25-hydroxyvitamin D [25(OH)D] levels in serum are associated with breast cancer risk.
Original paper ↗Read more →Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Levels in Breast Cancer Risk in Mali: A Case-Control Study
The aim of the current study was to determine the association between metabolites circulating in the blood, 25(OH)D and 1,25(OH)2D, and vitamin D levels with the risk of breast cancer in Malian women.
Original paper ↗Read more →Prognostic role of vitamin D receptor in digestive system tumours: A systematic review and preliminary meta-analysis
This study aimed to meta-analyse published studies on VDR and prognosis to verify the role of VDR in the prognosis of patients with digestive system tumours.
Original paper ↗Read more →The association of serum vitamin D3 and vitamin D binding protein levels before and after treatment with the response to neoadjuvant chemotherapy in Egyptian breast cancer patients: a prospective observational study
Vitamin D regulates cell growth and differentiation, encourages pro-apoptotic effect, stimulates antiangiogenic effect, and affects both innate and adaptive immunity.
Original paper ↗Read more →The Role of Diet and Lifestyle in Women with Breast Cancer: An Update Review of Related Research in the Middle East
In this review we examined the literature for evidence to link dietary choices and the rise in incidence and mortality of breast cancer among women in EMR.
Original paper ↗Read more →Vitamin D-related genetic variants as predictive biomarkers for breast cancer in Jordanian women
Vitamin D exerts a protective role in carcinogenesis by regulating signaling pathways implicated in tumor growth and progression.
Original paper ↗Read more →Vitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial
In this prospective randomized clinical study, we aim to investigate the effect of oral vitamin D supplementation during neoadjuvant systemic therapy (NST) on pathologic complete response (pCR).
Original paper ↗Read more →Vitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial
In this prospective randomized clinical study, we aim to investigate the effect of oral vitamin D supplementation during neoadjuvant systemic therapy (NST) on pathologic complete response (pCR).
Original paper ↗Read more →VDR FokI Polymorphism in Human Breast Cancer Cells: Study Summary
Concise summary of a verified primary study testing whether the VDR FokI polymorphism alters vitamin D signalling response magnitude in engineered MCF-7 cell models, with clear boundaries on what can and cannot be concluded.
Read more →Original sources
Vitamin D Supplementation Improves Pathological Complete Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Randomized Clinical Trial (PubMed)
Vitamin D Supplementation Improves Pathological Complete Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Randomized Clinical Trial (PubMed).
Publication details
Vitamin D Supplementation Improves Pathological Complete Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Randomized Clinical Trial (PubMed)